Ramucirumab (active substance) - analogs
Pharmgroups: Antitumor agents - monoclonal antibodies |
|||||||||
Prices in pharmacies: Instructions Ramucirumab | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. |
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
Ramucirumab included in the composition |
Prices in pharmacies |
Cyramza | 1645€ |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 67% Atezolizumab
- 57% Regorafenib
- 50% Nivolumab
- 40% Docetaxel
- 38% Topotecan
- 37% Bevacizumab
- 36% Calcium folinate
- 35% Pembrolizumab
- 33% Capecitabine
- 32% Cetuximab
- 31% Nimustine
- 31% Pentagastrin
- 29% Lomustine
- 27% Nintedanib
- 27% Vindesine
- 27% Everolimus
- 26% Inonotus Obliquus
- 26% Daratumumab
- 25% Epirubicin
- 25% Trastuzumab
- 24% Carubicin
- 23% Benzotef
- 23% Hydrazine sulfate
- 22% Oxaliplatin
- 21% Tegafur+Uracil [Tegafur]
- 21% Tegafur
- 21% Dactinomycin
- 21% Melphalan
- 20% Fluorouracil
- 20% Mitomycin
- 20% Aflibercept
- 20% Tegafur+Gimeracil+Oteracil [Tegafur]
- 20% Folinic acid
- 19% Irinotecan
- 18% Gemcitabine
- 18% Elotuzumab
- 17% Pantoprazole
- 17% Sarcolysin
- 17% Proxifeine
- 16% Rabeprazole
- 16% Ipilimumab
- 16% Doxorubicin
- 16% Lansoprazole
- 16% Paclitaxel
- 16% Isatuximab
- 16% Durvalumab
- 16% Idarubicin
- 15% Pertuzumab
- 15% Lorlatinib
- 15% Teniposide
Learn more about the selection of analogues
- The drug has «Ramucirumab» 51 analog by action, the most similar - Atezolizumab .
- Medical online service has selected the best substitutes for Ramucirumab based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Ramucirumab to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.